ArriVent BioPharma Reports Second Quarter 2026 Financial Results

Go back to ArriVent BioPharma Reports Second Quarter 2026 Financial Results
(NASDAQ: AVBP) Delayed: 30.08 +0.08 (0.27%)
Previous Close $30.00    52 Week High
Open $30.13    52 Week Low
Day High $30.45    P/E N/A 
Day Low $29.46    EPS
Volume 109,849